| Product NDC: | 62856-241 |
| Proprietary Name: | AcipHex Sprinkle |
| Non Proprietary Name: | rabeprazole sodium |
| Active Ingredient(s): | 10 mg/1 & nbsp; rabeprazole sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62856-241 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA204736 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130326 |
| Package NDC: | 62856-241-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (62856-241-30) > 1 GRANULE, DELAYED RELEASE in 1 CAPSULE |
| NDC Code | 62856-241-30 |
| Proprietary Name | AcipHex Sprinkle |
| Package Description | 30 CAPSULE in 1 BOTTLE (62856-241-30) > 1 GRANULE, DELAYED RELEASE in 1 CAPSULE |
| Product NDC | 62856-241 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rabeprazole sodium |
| Dosage Form Name | GRANULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130326 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | RABEPRAZOLE SODIUM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |